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Besides being a neuronal fuel, L-lactate is also a signal in the brain. Whether extracellular
L-lactate affects brain metabolism, in particular astrocytes, abundant neuroglial cells,
which produce L-lactate in aerobic glycolysis, is unclear. Recent studies suggested that
astrocytes express low levels of the L-lactate GPR81 receptor (EC50 ≈ 5 mM) that
is in fat cells part of an autocrine loop, in which the Gi-protein mediates reduction
of cytosolic cyclic adenosine monophosphate (cAMP). To study whether a similar
signaling loop is present in astrocytes, affecting aerobic glycolysis, we measured the
cytosolic levels of cAMP, D-glucose and L-lactate in single astrocytes using fluorescence
resonance energy transfer (FRET)-based nanosensors. In contrast to the situation
in fat cells, stimulation by extracellular L-lactate and the selective GPR81 agonists,
3-chloro-5-hydroxybenzoic acid (3Cl-5OH-BA) or 4-methyl-N-(5-(2-(4-methylpiperazin-
1-yl)-2-oxoethyl)-4-(2-thienyl)-1,3-thiazol-2-yl)cyclohexanecarboxamide (Compound 2),
like adrenergic stimulation, elevated intracellular cAMP and L-lactate in astrocytes,
which was reduced by the inhibition of adenylate cyclase. Surprisingly, 3Cl-5OH-BA and
Compound 2 increased cytosolic cAMP also in GPR81-knock out astrocytes, indicating
that the effect is GPR81-independent and mediated by a novel, yet unidentified,
excitatory L-lactate receptor-like mechanism in astrocytes that enhances aerobic
glycolysis and L-lactate production via a positive feedback mechanism.
Keywords: astrocytes, aerobic glycolysis, L-lactate receptor, cAMP, L-lactate
INTRODUCTION
Aerobic glycolysis, non-oxidative metabolism of glucose despite the presence of adequate levels of
oxygen, a phenomenon termed “the Warburg effect,” is an inefficient way to generate energy in the
form of ATP. The advantage of this process, however, appears to be in providing intermediates
for the biosynthesis of lipids, nucleic acids, and amino acids (Vander Heiden et al., 2009).
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These are needed for making new cells during division, such as in
cancer cells and in developing normal cells, and for cells engaged
in morphological reshaping, such as neural cells in the central
nervous system (CNS; Goyal et al., 2014).
At least in the brain, aerobic glycolysis appears to be regulated.
For example, during alerting, sensory stimulation, exercise, and
pathophysiological conditions, L-lactate production and release
are upregulated. Although it is still unclear how this takes place
at the cellular level, the process likely involves noradrenergic
neurons from locus coeruleus (LC; Dienel and Cruz, 2016).
L-lactate can be produced from glycogen stored in astrocytes,
an abundant glial cell type in the CNS, and can be used by
neurons and oligodendrocytes, which seem to require L-lactate
in addition to D-glucose for their optimal function, including
memory formation (Cowan et al., 2010; Barros, 2013; Gao et al.,
2016; Dong et al., 2017), myelin production, and the sustenance
of long axons (Lee et al., 2012; Rinholm and Bergersen, 2012).
In addition, L-lactate is considered to be neuroprotective against
various types of brain damage (Castillo et al., 2015) and is
required for cancer cell survival (Roland et al., 2014).
These effects suggest that L-lactate not only acts as a fuel but
also has extracellular signaling roles (Chen et al., 2005; Barros,
2013; Roland et al., 2014). L-lactate modulates the activity of
primary cortical neurons through a receptor-mediated pathway
(Bozzo et al., 2013), and the activation of astrocytes by LC
neurons results in the release of L-lactate, which back-excites
LC neurons and stimulates the further release of noradrenaline
(NA; Tang et al., 2014). These effects are supported by the
observation that the monocarboxylate transporter 2 (MCT2),
transporting L-lactate, is selectively co-located with glutamate
receptors at the postsynaptic membranes of fast-acting excitatory
synapses (Bergersen et al., 2001). Interestingly, L-lactate appears
to promote gene expression that mediates N-methyl-D-aspartate
(NMDA)-related neuronal plasticity (Yang et al., 2014) and the
expression of membrane metabolite receptors at the plasma
membrane (Castillo et al., 2015). L-lactate is known to mediate
cerebral vasodilatation, causing increased brain blood flow
(Gordon et al., 2007, 2008).
The notion of multiple signaling roles of L-lactate and its
widespread diffusion in tissues led to the concept of L-lactate
being a “volume transmitter” of metabolic information (Chen
et al., 2005) and perhaps also a gliotransmitter (Tang et al., 2014)
in the brain.
L-lactate signaling may occur through several mechanisms,
including the modulation of prostaglandin action (Gordon et al.,
2008), redox regulation (Brooks, 2009), and the activation of
the L-lactate-sensitive receptors, such as Gi-protein coupled
receptors GPR81 (Lauritzen et al., 2014) or the yet unidentified
plasma membrane receptors (Tang et al., 2014).
The L-lactate selectivity of the GPR81 receptor (EC50 ≈ 5 mM
for rat GPR81; Liu et al., 2009), also known as hydroxycarboxylic
acid receptor 1 (HCA1 or HCAR1), was discovered in adipose
tissues (reported EC50 range from 1 to 5 mM; Cai et al.,
2008; Liu et al., 2009), where GPR81 is highly expressed and
down-regulates the formation of cytosolic cyclic adenosine
monophosphate ([cAMP]i) by coupling to Gi-protein and
inhibiting the cAMP producing enzyme adenylate cyclase (AC),
thereby in an autocrine loop inhibiting lipolysis and promoting
energy storage (Ahmed et al., 2010). Whether a similar signaling
loop is present in astrocytes is not known and was explored
in this study. Quantitative RT-PCR analysis of human, rat, and
mouse brain tissue revealed the presence of mRNA GPR81 in the
brain, although at very low levels compared to adipose tissue (Liu
et al., 2009). Consistent with RT-PCR analysis, RNA sequencing
transcriptome databases revealed the presence of GPR81 mRNA
in individual types of mouse brain cells, including astrocytes
(Zhang et al., 2014; Sharma et al., 2015). Immunohistochemical
studies on mouse brain tissue slices also suggested the presence
of the GPR81 receptor in neurons, endothelial cells, and at low
density of expression in astrocytes, in particular in membranes of
perivascular astrocytic processes and not so much in perisynaptic
processes of astrocytes (Lauritzen et al., 2014; Morland et al.,
2017). The mechanism of how L-lactate via activation of a GPR81
receptor would modulate [cAMP]i, cytosolic levels of D-glucose
([glucose]i) and L-lactate ([lactate]i) in brain, in particular in
astrocytes that are actively involved in the regulation of brain
metabolism and produce L-lactate, is currently unknown.
In contrast to the situation in adipocytes, where the GPR81
receptor agonist decreases [cAMP]i (Ahmed et al., 2010), we
show here by fluorescence resonance energy transfer (FRET)
microscopy on single astrocytes expressing FRET-nanosensors
for cAMP and L-lactate that very high levels of extracellular
L-lactate and the agonist for the L-lactate GPR81 receptor
3-chloro-5-hydroxybenzoic acid (3Cl-5OH-BA; Dvorak et al.,
2012) elevate [cAMP]i and [lactate]i in astrocytes, as does
the activation of adrenergic receptors (ARs). The 3Cl-5OH-
BA-dependent elevation in [lactate]i and the extracellular L-
lactate-mediated rise in [cAMP]i, both act through the activation
of AC in astrocytes, as demonstrated by the use of an
AC inhibitor. Interestingly, in astrocytes from the L-lactate
specific GPR81 receptor knock-out (KO) mice, 3Cl-5OH-BA still
elevated [cAMP]i, indicating that the supposedly selective GPR81
agonist also activates a second, yet unidentified excitatory L-
lactate receptor-like mechanism. Pretreatment of rat astrocytes
with the sub-effective doses of 3Cl-5OH-BA reduced the L-
lactate-induced elevation in [cAMP]i, suggesting that 3Cl-
5OH-BA and L-lactate at least to some extent bind to the
same yet unidentified receptor. A new generation GPR81
selective high affinity agonist lead compound, Compound
2 (4-methyl-N-(5-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)-4-(2-
thienyl)-1,3-thiazol-2-yl)cyclohexanecarboxamide; Sakurai et al.,
2014) reproduced the cAMP enhancing effects of L-lactate
and 3Cl-5OH-BA, further supporting the existence of an
unidentified L-lactate receptor. The new excitatory L-lactate
receptor-mediated mechanism (“metabolic excitability”) may
participate in maintaining high [lactate]i in cells exhibiting
aerobic glycolysis, such as in astrocytes (Mächler et al., 2016),
contributing to the elevated levels of extracellular L-lactate in
comparison to the plasma levels (Abi-Saab et al., 2002). While
generating metabolic intermediates required for cell division and
morphological plasticity, this regulation presumably facilitates
the exit of L-lactate into the extracellular space, where it can
become an autocrine and paracrine signal. Since relatively high
concentrations of L-lactate (20 mM, but not 2 mM) are required
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for the increase in second messenger cAMP (the predicted brain
physiological concentrations of L-lactate are up to 2 mM), the
putative novel facilitatory L-lactate receptor-like mechanism may
have a role under conditions of very high extracellular L-lactate
that may occur during extreme exercise (Osnes and Hermansen,
1972; Matsui et al., 2017) or neuronal activity (for example during
seizures; During et al., 1994). Such a scenario may also be relevant
if local fluctuations of extracellular L-lactate concentration exist
in brain microdomains (Morland et al., 2015; Mosienko et al.,
2015).
MATERIALS AND METHODS
Cell Culture, Transfection, and Reagents
Primary cultures of astrocytes were prepared from cortices of 2–
3 and 1–4 days old rat and wild type (WT) or GPR81 KO mice
pups, respectively, as described previously (Schwartz and Wilson,
1992), and grown in high-glucose (25 mM) Dulbecco’s Modified
Eagle’s Medium containing 10% fetal bovine serum, 1 mM
sodium pyruvate, 2 mM L-glutamine, and 25 µg/ml penicillin-
streptomycin at 37◦C in 95% air–5% CO2 until reaching 70–
80% confluency. Confluent cultures were shaken at 225 rpm
overnight, and the medium was changed the next morning; this
was repeated three times. After the third overnight shaking,
the cells were trypsinized and put in flat tissue culture tubes
with 10 cm2 growth area. After reaching confluency, the cells
were trypsinized and plated on 22-mm diameter glass cover
slips coated with poly- L-lysine. By using quantitative PCR, we
verified that astrocytes from the GPR81 KO animals were devoid
of the GPR81 RNA transcript. The purity of rat astrocytes was
determined immunocytochemically using antibodies against the
astrocytic marker GFAP (Abcam, Cambridge, United Kingdom)
and>94% of imaged cultured cells were GFAP-positive (Stenovec
et al., 2016). 3T3-L1 fibroblasts (ATCC-LGC Standards, VA,
United States) were grown in high-glucose Dulbecco’s Modified
Eagle’s Medium containing 10% fetal bovine serum and 2 mM
L-glutamine. BT474 cancer cells (BT-474 Clone 5; ATCC R© CRL-
3247TM; ATCC-LGC Standards) were grown in Hybri-Care
medium (ATCC R© 46-XTM; ATCC-LGC Standards) supplemented
with 1.5 g/L sodium bicarbonate and 10% fetal bovine serum.
3T3-L1 and BT474 cells were grown in culture flasks with 25 cm2
growth area at 37◦C in 95% air–5% CO2. After reaching 70–80%
confluency, cells were trypsinized and plated on 22-mm diameter
glass cover slips coated with poly- L-lysine.
After 24–72 h, transfection with plasmids carrying FRET-
based nanosensors was performed with FuGENE R© 6 transfection
reagent according to manufacturer’s instructions (Promega Co.,
Madison, WI, United States). Transfection medium contained no
serum or antibiotics.
GPR81 KO and WT mice (Ahmed et al., 2010) in C57Bl/6N
background were bred in Oslo from founder mice obtained
from Stefan Offermanns, Max-Planck-Institute for Heart and
Lung Research, Department of Pharmacology, D-61231 Bad
Nauheim, Germany. The experimental animals were cared
for in accordance with the International Guiding Principles
for Biomedical Research Involving Animals developed by the
Council for International Organizations of Medical Sciences
and the Animal Protection Act (Official Gazette RS, No.
38/13). The experimental protocol was approved by The
Administration of the Republic of Slovenia for Food Safety,
Veterinary and Plant Protection (Republic of Slovenia, Ministry
of Agriculture, Forestry and Food, Ljubljana), Document
No. U34401-47/2014/7, signed by Barbara Tomše, DVM. All
experiments were performed on rat astrocytes isolated from at
least two different animals. All chemicals were from Sigma-
Aldrich (St. Louis, MO, USA) unless otherwise noted.
FRET Measurements of [cAMP]i and PKA
Activity
Cells expressing the FRET-based cAMP nanosensor Epac1-
camps (Nikolaev et al., 2004) or the PKA nanosensor AKAR2
(Zhang et al., 2005) were examined 24–48 h after transfection
with a Plan NeoFluoar 40×/1.3 NA oil differential interference
contrast (DIC) immersion objective (Carl Zeiss, Jena, Germany)
using a Zeiss LSM510 META confocal microscope (Carl Zeiss,
Jena, Germany). Cells were excited at 458 nm, and images
(512 × 512) were acquired every 3.5 s using lambda stack
acquisition. Emission spectra were collected from the META
detector in 8 channels (lambda stack) ranging from 470 nm
to 545 nm, each with a 10.7-nm width. Two-channel [cyan
fluorescent protein (CFP) and yellow fluorescent protein (YFP)]
images were generated using the analytical software Extract
channels (Zeiss LSM510 META, Carl Zeiss, Jena, Germany).
Channels with emission spectra at 470 and 481 nm and emission
spectra at 513, 524, and 534 nm were extracted to the CFP and
YFP channels, respectively. YFP and CFP fluorescence intensities
were quantified within a region of interest (ROI) selected for
individual cells expressing Epac1-camps or AKAR2 using the
LSM510 META software.
In some experiments, astrocytes expressing the Epac1-camps
FRET nanosensor, were examined 24 h after transfection
with a fluorescence microscope Zeiss Axio Observer.A1 (Zeiss,
Oberkochen, Germany) with a CCD camera and monochromator
Polychrome V (Till Photonics, Graefelfing, Germany) as a
monochromatic source of light with a wavelength 436 nm/10 nm.
Dual emission intensity ratios were recorded using an image
splitter (Optical Insights, Tucson, AZ, United States) and two
emissions filters (465/30 nm for CFP and 535/30 nm for YFP).
Images were acquired every 3.5 s with an exposure time of 0.1 s.
CFP and YFP fluorescence intensities were obtained from the
integration of ROI over the entire cell using Life Acquisition
software (Till Photonics, Graefelfing, Germany).
In the graphs, the FRET ratio signal was reported as
the ratio of the CFP/YFP (Epac1-camps) and YFP/CFP
(AKAR2) fluorescence signals after subtracting the background
fluorescence from the signals using Excel (Microsoft, Seattle, WA,
United States). The values of the FRET signals were normalized
to 1.0. An increase in the FRET ratio signal reflects an increase in
the [cAMP]i and the PKA activity.
Initially, astrocytes were kept in extracellular solution (10 mM
Hepes/NaOH, pH 7.2, 10 mM D-glucose, 131.8 mM NaCl,
1.8 mM CaCl2, 2 mM MgCl2, and 5 mM KCl) or extracellular
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solution with sodium bicarbonate (10 mM Hepes/NaOH, pH 7.2,
10 mM D-glucose, 131.8 mM NaCl, 1.8 mM CaCl2, 2 mM MgCl2,
5 mM KCl, 0.5 mM NaH2PO4 × H2O, and 5 mM NaHCO3)
and were then treated with various reagents following a 100-s
baseline: 1 µM NA, 10 µM isoprenaline (ISO), 2 or 20 mM L-
lactate (osmolality was adjusted by lowering NaCl in extracellular
solution containing sodium bicarbonate) and 0.5 mM 3Cl-5OH-
BA. In some experiments cell were after initial a 100-s baseline
pretreated with 100 µM 2′,5′-dideoxyadenosine (DDA) or 50 µM
3Cl-5OH-BA for 450 s and then stimulated with 20 mM L-lactate
in the presence of DDA or 3Cl-5OH-BA, respectively. The
4-methyl-N-(5-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)-4-(2-
thienyl)-1,3-thiazol-2-yl)cyclohexanecarboxamide (Compound
2; Sakurai et al., 2014) was custom synthesized (ABX advanced
biochemical compounds, D-01454 Radeberg, Germany). After
the initial 90–100-s baseline, WT and GPR81 KO astrocytes were
treated with GPR81 receptor agonist 3Cl-5OH-BA (0.5 mM)
or Compound 2 (50 nM) and recorded for another 300 s.
In control experiments, astrocytes were treated only with
extracellular solution (Vehicle). Extracellular solution osmolality
was ∼300 mOsm, measured with a freezing point osmometer
(Osmomat030, Gonotech GmbH, Germany).
FRET Measurements of [glucose]i and
[lactate]i
Astrocytes, 3T3-L1 embryonic preadipocyte fibroblast cells
and BT474 cancer cells expressing the FRET-based glucose
nanosensor FLII12Pglu-700µδ61 (Takanaga et al., 2008;
Prebil et al., 2011) or the FRET-based lactate nanosensor
Laconic (San Martin et al., 2013) were examined 16–48 h
after transfection with a fluorescence microscope (Zeiss Axio
Observer.AI, Zeiss, Oberkochen, Germany), with a CCD
camera and monochromator Polychrome V (Till Photonics,
Graefelfing, Germany) as a monochromatic source of light with
a wavelength 436 nm/10 nm. Dual emission intensity ratios were
recorded using an image splitter (Optical Insights, Tucson, AZ,
United States) and two emission filters; 465/30 nm for ECFP or
mTFP and 535/30 nm for EYFP or Venus. Images were acquired
every 10 s with an exposure time of 0.1 s. The background
fluorescence was subtracted from individual EYFP or Venus and
ECFP or mTFP fluorescence signals. The FRET ratio signals,
EYFP/ECFP (FLII12Pglu-700µδ6) and mTFP/Venus (Laconic),
were obtained from the integration of the ratio signal over
the entire cell using Life Acquisition software (Till Photonics,
Graefelfing, Germany). The values of the FRET signals were
normalized to 1.0. An increase in the FRET ratio signal reflects
increases in the [glucose]i and [lactate]i.
Initially, cells were kept in extracellular solution with sodium
bicarbonate (10 mM Hepes/NaOH, pH 7.2, 3 mM D-glucose,
135.3 mM NaCl, 1.8 mM CaCl2, 2 mM MgCl2, 5 mM
KCl, 0.5 mM NaH2PO4 × H2O, and 5 mM NaHCO3), and
were then treated with various reagents following a 200-s
baseline: 200 µM ISO, 200 µM NA, 2 or 20 mM L-lactate,
0.5 mM 3Cl-5OH-BA, and 6 mM α-cyano-4-hydroxycinnamate
(CHC). In some experiments, cells were, after an initial 200
1www.addgene.org
s-baseline, pretreated with 100 µM DDA for 450 s and then
stimulated with 0.5 mM 3Cl-5OH-BA in the presence of DDA.
Extracellular solution osmolality was ∼300 mOsm, measured
with a freezing point osmometer (Osmomat030, Gonotech
GmbH, Germany).
Extraction of mRNA and Quantitative
Real-Time PCR (qPCR)
Rat, WT mouse, and GPR81 KO mouse astrocytes were
cultured in six-well plates. Total RNA was extracted from
cultured astrocytes with the RNeasy Mini Plus Kit (Qiagen,
Hilden, Germany). cDNA was synthesized from total RNA using
the High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Thermo Fisher Scientific, Vilnius, Lithuania). qPCR
was performed on ABI PRISM SDS 7500 (Applied Biosystems,
Thermo Fisher Scientific) in a 96-well format using TaqMan
Universal PCR Master Mix (Applied Biosystems, Thermo Fisher
Scientific, Foster City, United States) and gene expression
assays for GPR81 (Rn03037047_sH) and 18S rRNA (TaqMan
Endogenous Control). Standard quality controls were performed
in line with the MIQE Guidelines (Bustin et al., 2009). Expression
level of GPR81 mRNA was calculated as gene expression
ratio (GPR81 mRNA/18S rRNA) according to the equation:
ECt,18S rRNA18S rRNA /E
Ct,GPR81
GPR81 , where E is the PCR efficiency and Ct is
the threshold cycle for the reference (18S rRNA) or the target
(GPR81) gene (Ruijter et al., 2009; Tuomi et al., 2010). PCR
efficiency was estimated using the LinRegPCR program (Ruijter
et al., 2009; Tuomi et al., 2010).
Statistical Analysis
Single-exponential increase to maximum functions [F = F0 +
c × (1 − exp(−t/τ))] were fitted to the diagrams with FRET
ratio signals using SigmaPlot. The time constant (τ) and the
FRET ratio signal amplitudes (c) were determined from the
fitted curves. F is the FRET ratio signal at time t, F0 is the
baseline FRET ratio signal, c is FRET ratio signal amplitude
of F − F0, and τ is the time constant of the individual
exponential component. In some experiments, the initial rate
of the FRET signal increase (1FRET/1time) after the addition
of various reagents was calculated as the slope of the linear
regression function [1FRET (%) = slope (%/min) × 1time
(min)] fitting the initial FRET signal decrease or increase. In these
experiments, the amplitude of the 1FRET (%) was determined
by subtracting the mean FRET ratio signal of the first 100 s from
the last 100 s upon stimulation or vice versa, if the FRET signal
increased.
The average traces of the predominant responses are presented
in the figures for individual stimuli; all other responses are listed
in Table 1. Unless stated otherwise, the Student’s t-test was
performed to determine statistical significance. P < 0.05 was
considered to be significant.
RESULTS
We studied here how extracellular L-lactate and agonists
of the L-lactate GPR81 receptor affect cAMP signaling and
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TABLE 1 | Responsiveness of astrocytes to adrenergic and L-lactate receptor activation.
FRET nanosensor Stimulus n (%) n (%) n (%) n (%) n
increase decrease transient decrease unresponsive all
Rat astrocytes
cAMP ISO (10 µM) 8 (100%) 0 (0%) 0 (0%) 0 (0%) 8
NA (1 µM) 16 (100%) 0 (0%) 0 (0%) 0 (0%) 16
L-lactate (20 mM) 7 (36.8%) 3 (15.8%) 0 (0%) 9 (47.4%) 19
3Cl-5OH-BA (0.5 mM) 9 (42.9%) 2 (9.5%) 0 (0%) 10 (47.6%) 21
PKA L-lactate (2 mM) 0 (0%) 0 (0%) 0 (0%) 7 (100%) 7
L-lactate (20 mM) 8 (57.1%) 1 (7.1%) 0 (0%) 5 (35.7%) 14
3Cl-5OH-BA (0.5 mM) 9 (56.3%) 2 (12.5%) 0 (0%) 5 (31.3%) 16
Glucose ISO (200 µM) 5 (16.1%) 0 (%) 0 (0%) 26 (83.9%) 31
NA (200 µM) 8 (40%) 0 (%) 0 (0%) 12 (60%) 20
L-lactate (2 mM) 0 (0%) 0 (0%) 0 (0%) 11 (100%) 11
L-lactate (20 mM) 3 (15%) 4 (20.0%) 13 (65.0%) 0 (0%) 20
3Cl-5OH-BA (0.5 mM) 1 (5.3%) 13 (68.4%) 1 (5.3%) 4 (21.1%) 19
Lactate ISO (200 µM) 10 (63%) 0 (0%) 0 (0%) 6 (27%) 16
NA (200 µM) 8 (88.9%) 0 (0%) 0 (0%) 1 (11.1%) 9
L-lactate (20 mM) 14 (93.3%) 0 (0%) 0 (0%) 1 (6.7%) 15
3Cl-5OH-BA (0.5 mM) 14 (100%) 0 (0%) 0 (0%) 0 (0%) 14
Mouse astrocytes
cAMP WT 3Cl-5OH-BA (0.5 mM) 11 (68.8) 0 (0) 0 (0) 5 (31.2) 16
Compound 2 (50 nM) 10 (66.7%) 0 (0) 0 (0) 5 (33.3%) 15
KO GPR81 3Cl-5OH-BA (0.5 mM) 11 (73.3) 0 (0) 0 (0) 4 (26.7) 15
Compound 2 (50 nM) 11 (100%) 0 (0) 0 (0) 0 (0) 11
ISO, isoprenaline; NA, noradrenaline; 3Cl-5OH-BA, 3-chloro-5-hydroxybenzoic acid; Compound 2, 4-methyl-N-(5-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)-4-(2-thienyl)-
1,3-thiazol-2-yl)cyclohexanecarboxamide; n, number of cells studied. The increase or decrease in the FRET ratio signal was set by determining a threshold of 3 standard
deviations of the average signal measured prior to the application of agents (baseline), as described (Horvat et al., 2016). The frequency of unresponsive cells did not
differ in KO group compared to WT group, when treated with 3Cl-5OH-BA (P = 0.78). The frequency of unresponsive cells was significantly lower in KO group compared
to WT group, when treated with Compound 2 (P = 0.03; chi-square statistic).
changes in the intracellular levels of metabolites in isolated
astrocytes, which can express the GPR81 receptor (Lauritzen
et al., 2014; Sharma et al., 2015) and mRNA for GPR81
can be measured in these cells (Supplementary Figure S1).
Real-time FRET imaging of cultured cortical astrocytes,
expressing FRET-nanosensors for cAMP, glucose, and lactate was
performed.
Extracellular L-Lactate and GPR81
Lactate Receptor Agonists Increase
[cAMP]i in Astrocytes
We performed real-time monitoring of [cAMP]i while
extracellular L-lactate or the GPR81 lactate receptor agonist
3Cl-5OH-BA (Dvorak et al., 2012; Liu et al., 2012) were applied.
Using the FRET-nanosensor for cAMP Epac1-camps, in 7
(37%) out of 19 cells an increase in [cAMP]i was measured
when a high concentration of L-lactate (20 mM) was applied
(Figure 1A). Decreased [cAMP]i was measured only in 3
(16%) cells out of 19 (Table 1). Although GPR81 receptor
in adipocytes is coupled to Gi-proteins decreasing [cAMP]i
(Ahmed et al., 2010), the observed L-lactate-mediated elevation
in [cAMP]i in 37% of cells studied might be due to the
activation of a Gs-protein coupled to L-lactate GPR81 receptor,
as a similar rise in [cAMP]i was recorded in astrocytes by
adding the selective GPR81 receptor agonist 3Cl-5OH-BA
(0.5 mM, Figure 1B); 9 (43%) of 21 cells responded with
an increase (Figure 1B) and 2 (10%) with a small decrease
in [cAMP]i (Table 1). Inhibition of AC activity by 100 µM
DDA (Vardjan et al., 2014) reduced the 20 mM extracellular
L-lactate-induced increase in [cAMP]i by ∼50 % (Figure 3A),
indicating that in the majority of astrocytes, extracellular
L-lactate activates the cAMP pathways via binding to receptors
that activate AC.
To verify whether the 3Cl-5OH-BA-induced increase in
[cAMP]i is mediated via the GPR81 lactate receptor, we
used isolated astrocytes from the GPR81 KO mice (Ahmed
et al., 2010). Interestingly, even in GPR81 KO astrocytes, the
application of 3Cl-5OH-BA (0.5 mM), like in WT astrocytes,
elicited an increase in [cAMP]i (Figure 2 and Table 1). Similar
results were obtained by using a much higher affinity GPR81
receptor agonist Compound 2 (Sakurai et al., 2014; histograms
in Figures 2C,D; Table 1), suggesting that these agonists activate
in astrocytes a second, yet unidentified receptor-like mechanism,
thus resembling the unidentified L-lactate receptor in neurons,
coupled to Gs-protein increasing the production of cAMP (Tang
et al., 2014).
To see if L-lactate and GPR81 agonist 3Cl-5OH-BA target
the same, yet unidentified receptor-like mechanism, sharing
the binding on the receptor, we pretreated rat astrocytes with
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FIGURE 1 | Application of L-lactate and 3Cl-5OH-BA increases [cAMP]i and the intracellular PKA activity in rat astrocytes. (A,B) Representative (above) and mean
time-course (below) of the Epac1-camps FRET ratio signal upon the addition of (A) L-lactate (20 mM) and (B) 3Cl-5OH-BA (0.5 mM), a selective agonist of the
GPR81 receptor. Data are expressed as percentages of the inverse FRET ratio signal (CFP/YFP) relative to the baseline values. Single exponential rise functions were
fitted to the curves: (A, above) FRET ratio = [0.98 ± 0.01] + [0.06 ± 0.01] × (1 – exp(–t/[25.00 ± 5.63 s])), (A, below) FRET ratio = [1.00 ± 0.00] +
[0.05 ± 0.00] × (1 – exp(–t/[ 35.71 ± 2.55 s])), and (B, above) FRET ratio = [0.94 ± 0.00] + [0.06 ± 0.01] × (1 – exp(–t/[41.49 ± 5.85 s])), (B, below) FRET
ratio = [1.00 ± 0.00] + [0.07 ± 0.00] × (1 – exp(t/[66.67 ± 4.42 s])). Note that the addition of L-lactate and 3Cl-5OH-BA increased the FRET ratios, indicating
increases in [cAMP]i. Each data point represents the mean ± s.e.m. (C) Mean changes in the FRET ratio (1FRET ratio) and mean time-constants (τ) upon L-lactate
and 3Cl-5OH-BA stimulation. Changes in FRET ratio are expressed as percentages relative to the initial values. The numbers by the bars depict the number of cells
analyzed. Data are shown as the means ± s.e.m. (D,E) Representative (above) and mean time-course (below) of the AKAR2 FRET ratio signal upon addition of
(D) L-lactate (20 mM) and (E) 3Cl-5OH-BA (0.5 mM). Data are expressed as percentages of the FRET ratio signals (YFP/CFP) relative to the baseline ratio values.
Single exponential rise functions were fitted to the curves: (A, above) FRET ratio = [1.01 ± 0.00] + [0.10 ± 0.00] × (1 – exp(–t/[90.91 ± 8.26 s])), (A, below) FRET
ratio = [1.00 ± 0.00] + [0.08 ± 0.00] × (1 – exp(–t/[111.11 ± 9.91 s])), and (B, above) FRET ratio = [0.97 ± 0.01] + [0.10 ± 0.01] × (1 – exp(–t/[47.62 ± 4.54 s])),
(B, below) FRET ratio = [0.98 ± 0.00] + [0.12 ± 0.00] × (1 – exp(–t/[71.43 ± 5.10 s])). Note that the addition of L-lactate and 3Cl-5OH-BA increased the FRET ratios,
indicating increased PKA activity. Each data point represents the mean ± s.e.m. (F) Mean changes in the FRET ratio (1FRET ratio) and mean time-constants (τ)
upon L-lactate and 3Cl-5OH-BA stimulation. The numbers by the bars depict the number of cells analyzed. Data shown are in the format of the mean ± s.e.m. Data
for every set of experiment was acquired from at least two different animals.
the sub-effective dose of GPR81 receptor agonist 3Cl-5OH-BA
(50 µM). The application of 50 µM 3Cl-5OH-BA is ineffective
in increasing [cAMP]i in astrocytes, since the application of 3Cl-
5OH-BA results in a FRET ratio signal change (1.63± 0.38 %,
n = 13), not significantly different to the vehicle-induced response
in controls (1.01 ± 0.46 %, n = 13, P = 0.31). However,
the sub-effective dose of 3Cl-5OH-BA (50 µM) reduced the
L-lactate-induced elevation in [cAMP]i (Supplementary Figure
S4), indicating that in addition to interacting with the GPR81
lactate receptor, this supposedly selective GPR81 receptor agonist
(Dvorak et al., 2012), binds like L-lactate to the yet unidentified
receptor in astrocytes.
Furthermore, to evaluate whether the L-lactate receptor-like
mechanism elevates [cAMP]i and consequently also activates the
cAMP-effector protein kinase A (PKA) we used the AKAR2,
PKA activation nanosensor (Zhang et al., 2005). Significant
increase in PKA activity was recorded (Figures 1D,E) when
astrocytes were exposed to 20 mM L-lactate in 57% of 14 cells
or to 0.5 mM 3Cl-5OH-BA in 56% of 16 cells (Table 1). The
differences in the responsiveness of cells between Epac1-camps
and AKAR2 nanosensors (∼40% vs. ∼60%, respectively) may
be due to a higher sensitivity of the AKAR2 nanosensor, since
Epac1-camps can only detect [cAMP]i that is >100 nM (Börner
et al., 2011). No changes in PKA activity were observed, when
a 10-fold lower concentration of L-lactate (2 mM) was applied
to cells (Supplementary Figure S5). The time-course and the
extent of increase in the PKA activity were similar for both
types of stimuli, L-lactate and 3Cl-5OH-BA (Figure 1F). We
observed a delay between the addition of L-lactate or 3Cl-
5OH-BA and subsequent increase in AKAR2 FRET ratio signal,
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FIGURE 2 | Stimulation with 3Cl-5OH-BA and Compound 2 elicits persistent
increase in [cAMP]i in WT and GPR81 KO mice astrocytes expressing the
FRET nanosensor Epac1-camps. (A,B) Mean normalized time-courses of the
Epac1-camps FRET ratio signal after stimulation with 3Cl-5OH-BA (0.5 mM) in
(A) WT (n = 16) and (B) GPR81 KO (n = 15) cultured mouse astrocytes at
t = 100 s (black lines). Changes in the FRET ratio signal are expressed as
percentages of the inverse FRET ratio signal (CFP/YFP) relative to the baseline
values. The monophasic exponential increase in the FRET signal (represented
by the CFP/YFP ratio) after 3Cl-5OH-BA stimulation reflects an increase in
[cAMP]i. Each data point represents mean ± s.e.m. (C,D) Mean changes in
the Epac1-camps FRET ratio signal (1FRET; C) and initial rates of the FRET
ratio signal increase (1FRET/1t; D) after the addition of 3Cl-5OH-BA (black
bars) and Compound 2 (gray bars) in WT and GPR81 KO astrocytes.
Numbers by the error bars depict the number of cells analyzed. (∗P < 0.05;
Mann Whitney U test) Data for every set of experiment was acquired from at
least two different animals except for Compound 2.
determined from the intersection of the reference baseline with
the exponential curve (time of delay was 35 ± 7 s (20 mM
L-lactate) vs. 49 ± 7 s (0.5 mM 3Cl-5OH-BA); P = 0.19),
consistent with PKA activation occurring downstream of cAMP
production.
The observation that a 10-fold lower concentrations of
3Cl-5OH-BA (50 µM vs. 500 µM) and L-lactate (2 mM vs.
20 mM) does not affect cAMP levels and PKA activity in
astrocytes, respectively, indicates that astrocytes respond to
extracellular 3Cl-5OH-BA and L-lactate in a concentration-
dependent manner, further suggesting that these two agonists in
astrocytes cause a rise in cAMP via activation of an excitatory
receptor-like mechanism in the plasma membrane.
Extracellular L-Lactate and GPR81
Receptor Agonist Trigger Similar
Increases in [lactate]i in Astrocytes and
Cancer Cells as Adrenergic Stimulation
via Adenylate Cyclase Activation
Brain-based aerobic glycolysis (Goyal et al., 2014) is upregulated
by noradrenergic stimuli affecting astrocyte metabolism (Dienel
and Cruz, 2016). It has been reported that AR stimulation elevates
astrocytic [cAMP]i (Vardjan et al., 2014; Horvat et al., 2016)
and also intracellular concentration in free glucose ([glucose]i;
Prebil et al., 2011). We show here using lactate FRET nanosensor
Laconic (San Martin et al., 2013) that astrocytes respond to
AR activation also with an increase in intracellular L-lactate
(Supplementary Figure S2) from its basal to the new steady state
levels.
Although we have observed that in all studied astrocytes
exposed to ISO (n = 8) and NA (n = 16) the [cAMP]i
increased, the elevations in [glucose]i were only rarely observed,
when cells were treated with selective β-AR agonist ISO [5
(16%) of the 31 cells]. The percentage of responsive cells,
however, increased by twofold, when cells were exposed to NA,
nonselective AR agonist [8 (40%) of the 20 cells; Table 1]
and when cells were treated with selective α1-AR agonist
(data not shown), implying the role of Ca2+ in the elevation
of [glucose]i. In contrast to measurements of [glucose]i, the
majority of astrocytes (63%) responded to ISO application
with an elevation in [lactate]i (10 out of 16 cells); 89% of
astrocytes (8 out of 9 cells) responded with enhanced [lactate]i
to stimulation by NA (Supplementary Figure S2C, Table 1).
The time-course of the measured [cAMP]i increase was faster
compared to that of [glucose]i and [lactate]i (Supplementary
Figure S3).
Since L-lactate and GPR81 agonist 3Cl-5OH-BA (Figure 1),
like β-AR agonists (Supplementary Figure S2; Vardjan et al.,
2014; Horvat et al., 2016) increase [cAMP]i and PKA activity
in astrocytes, we further examined whether extracellular L-
lactate or the GPR81 agonist 3Cl-5OH-BA affect [glucose]i and
[lactate]i in astrocytes. Figure 4 shows that both extracellular L-
lactate (20 mM) and 3Cl-5OH-BA (0.5 mM) decreased [glucose]i
in the majority of studied cells. In the former case, the
decrease was transient (65% of 20 cells responded), but the
change was persistent in the latter case, where 68% of 19 cells
responded. Interestingly, these treatments elevated [lactate]i in
93% of 15 cells (L-lactate) and in all 14 (100%) cells in case
of 3Cl-5OH-BA (Figures 3B (left panel), 5). The increase in
[lactate]i was faster when the cells were exposed to extracellular
L-lactate than 3Cl-5OH-BA, likely due to the entry of L-lactate
into the cytosol through the plasma membrane MCTs. The
extent of [lactate]i elevation was more than twofold higher
upon the addition of L-lactate vs. 3Cl-5OH-BA (Figure 5C),
which was expected due to L-lactate entry into the cytoplasm
via the MCTs and possibly channels (Sotelo-Hitschfeld et al.,
2015).
A few cells responded with a [glucose]i increase to L-lactate or
3Cl-5OH-BA stimulation [3 (15%) and 1 (5%) cells, respectively],
but no cell responded with a decrease in [lactate]i to these stimuli.
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FIGURE 3 | Inhibition of AC reduces the L-lactate- and 3Cl-5OH-BA-induced increase in [cAMP]i and [lactate]i (A,B, panels i) Mean time-courses of FRET ratio
signal changes normalized to the maximum signal change for (A,i) Epac1-camps upon addition of 20 mM L-lactate and (B,i) Laconic upon addition of 0.5 mM
3Cl-5OH-BA (black lines) in the absence (white circles) and presence (black circles) of 100 µM DDA, an inhibitor of AC. Each data point represents mean ± s.e.m.
(A,B, panels ii) Mean relative changes in FRET ratio (Rel. 1FRET ratio) upon L-lactate (A) and (B) 3Cl-5OH-BA stimulation in the absence and presence of DDA.
Relative 1FRET values (%) were calculated by dividing individual 1FRET values with the average 1FRET value upon L-lactate or 3Cl-5OH-BA stimulation. Note that
the inhibition of AC by DDA causes ∼50 % reduction in L-lactate-induced increase in [cAMP]i in astrocytes and a ∼30–60% reduction in 3Cl-5OH-BA-induced
increase in [lactate]i in astrocytes, 3T3-L1 and BT474 cells. In BT474 cells the application of 3Cl-5OH-BA initiated a transient reduction in [lactate]i that was
diminished in the presence of DDA. Numbers adjacent to black bars represent number of cells. Data are in the format of the mean ± s.e.m (∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001). Data for every set of experiment was acquired from at least two different animals.
As in the case of the cAMP-dependent PKA activity (n = 7), the
addition of 2 mM L-lactate had no significant effect on [glucose]i
(n = 11; Supplementary Figure S5), further indicating that
astrocytes respond to extracellular L-lactate in a concentration-
dependent manner.
Taken together these results show that in astrocytes,
extracellular L-lactate and 3Cl-5OH-BA trigger an elevation in
[lactate]i, likely via the cAMP-mediated activation of glucose
consumption, as decreased [glucose]i was recorded in the
majority of the 3Cl-5OH-BA-treated cells. Moreover, inhibition
of AC by 100 µM DDA (Vardjan et al., 2014), reduced the
3Cl-5OH-BA-induced increase in [lactate]i in astrocytes. We
have observed inhibition of 3Cl-5OH-BA-induced increase in
[lactate]i with DDA also in 3T3-L1 embryonic murine cells with
genetic trait as seen in human ectodermal cancers (Leibiger et al.,
2013) and in human mammary ductal carcinoma BT474 cells
(Figure 3B). Both cell lines were shown to be positive for the
GPR81 receptor (Liu et al., 2009; Staubert et al., 2015), indicating
that AC activation by a membrane receptor is responsible
for the increase in [lactate]i in cells that exhibit aerobic
glycolysis such as astrocytes and cancer cells (Supplementary
Table S1).
Receptor-Regulated Increase in the Rate
of Aerobic Glycolysis in Astrocytes
Aerobic glycolysis in the brain is likely mediated by astrocytes,
since these cells strongly favor L-lactate as the end glycolytic
product whether or not oxygen is present (Halim et al., 2010).
To measure the glycolytic rate in these cells, we estimated the
maximal initial rate of [lactate]i increase in the presence of CHC
(6 mM), a non-specific inhibitor of membrane MCTs (MCTs
1-4). In the absence of L-lactate exchange through the plasma
membrane, the predominant pathway available for cytosolic
L-lactate accumulation is considered to be glycolytic L-lactate
production. Although cytosolic L-lactate may be transported to
mitochondria for oxidation in astrocytes (Passarella et al., 2008),
in the presence of MCT blockers the initial rate of cytosolic
L-lactate accumulation, measured as 1FRET/1t, is comparable
to that of the initial rate of aerobic glycolysis. Figure 6A, ii
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FIGURE 4 | Application of L-lactate and 3Cl-5OH-BA decreases [glucose]i in
astrocytes. (A,B) Representative (above) and mean time-course (below) of
FLII12Pglu-700µδ6 FRET ratio signal, reporting [glucose]i, upon the addition
of (A) L-lactate (20 mM) and (B) 3Cl-5OH-BA (0.5 mM). Data are expressed
as the percentages of the FRET ratio signals (EYFP/ECFP) relative to the
baseline ratio values. The initial rate of change in [glucose]i was determined by
fitting the regression lines to the signal decreases; 1FRET (%) = –k
(%/min) × 1t (min), where t is the time and the k–slope is the initial 1FRET
decline: k(A,above) = 4.94 ± 0.28 %/min, k(A,below) = 2.90 ± 0.36 %/min, and
k(B,above) = 2.32 ± 0.29 %/min, k(B,below) = 1.05 ± 0.11 %/min. Note that the
addition of L-lactate transiently decreased the FRET ratio, while the
3Cl-5OH-BA persistently decreased the FRET ratio. Each data point
represents the mean ± s.e.m. (C) Mean changes in the FRET ratio (1FRET
ratio; left) and initial rates in the FRET ratio decrease (1FRET/1t; right) upon
L-lactate and 3Cl-5OH-BA stimulation. Numbers adjacent to the bars depict
the number of cells analyzed. Data shown are in the format of the
mean ± s.e.m (∗P < 0.05, ∗∗∗P < 0.001). Data for every set of experiment
was acquired from at least two different animals.
shows that upon the addition of CHC, the initial maximal rate
of the [lactate]i increase was 3.2 ± 0.6 %/min (P < 0.001),
which was consistent with previous results (Sotelo-Hitschfeld
et al., 2015). It appears that this effect is not an artifact,
as vehicle addition did not affect the [lactate]i (Figure 6B;
P = 0.18). With the addition of 3Cl-5OH-BA (0.5 mM), the
rate of [lactate]i increase was approximately twofold higher
than the resting rate of glycolysis. NA (200 µM) appeared
as a weaker stimulus of [lactate]i increase in comparison to
3Cl-5OH-BA (0.5 mM) (Figure 6B) at the concentrations of
respective agonists used. The strongest effect on the measured
rate in the [lactate]i increase was recorded when extracellular
L-lactate (20 mM) was applied. This was expected, as L-lactate
can enter the cytoplasm via the MCTs. Consistent with this
FIGURE 5 | Comparison of increases in [lactate]i by extracellular L-lactate and
3Cl-5OH-BA in astrocytes. (A,B) Representative (above) and mean
time-course (below) of the Laconic FRET ratio signal upon the addition of
(A) L-lactate (20 mM) and (B) 3Cl-5OH-BA (0.5 mM). Data are expressed as
the percentages of FRET ratio signals (mTFP/Venus) relative to the baseline
ratio values. Single exponential rise functions were fitted to the curves:
(A, above) FRET ratio = [0.81 ± 0.02] + [0.44 ± 0.02] × (1 – exp
(–t/[18.80 ± 1.10 s])), (A, below) FRET ratio = [1.02 ± 0.01] + [0.24 ± 0.01] ×
(1 – exp(–t / [39.06 ± 2.44 s])), and (B, above) FRET ratio = [1.00 ± 0.00] +
[0.06 ± 0.00] × (1 – exp(–t/[116.28 ± 14.87 s])), (B, below) FRET
ratio = [0.98 ± 0.00] + [0.09 ± 0.00] × (1 – exp(–t/[54.05 ± 2.34 s])). Note
that the addition of L-lactate and 3Cl-5OH-BA increased the FRET ratios,
indicating an increase in [lactate]i. Each data point represents the
mean ± s.e.m. (C) Mean changes in the FRET ratio (1FRET ratio; left) and
mean time-constants (τ; right) upon L-lactate and 3Cl-5OH-BA stimulation.
Numbers by the error bars depict the number of cells analyzed. Data shown
are in the format of the mean ± s.e.m (∗∗∗P < 0.001). Data for every set of
experiment was acquired from at least two different animals.
finding, when L-lactate was added in the presence of the MCT
blocker CHC, the increase in [lactate]i was strongly attenuated in
comparison to the conditions in the absence of CHC (data not
shown).
Taken together, the results indicate that in astrocytes,
extracellular L-lactate mediates an increase in [cAMP]i that
stimulates aerobic glycolysis and elevates [lactate]i via a receptor-
mediated pathway involving AC.
DISCUSSION
Here we studied whether extracellular L-lactate affects aerobic
glycolysis via G-protein coupled L-lactate receptors, such as
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FIGURE 6 | The resting rate of glycolysis and lactate production is modulated by noradrenaline and 3Cl-5OH-BA in astrocytes. (A) Representative (i) and mean (ii)
time-course of Laconic FRET ratio signal upon addition of 6 mM CHC. Data are expressed as the percentage of the FRET ratio signal (mTFP/Venus) relative to the
baseline ratio values. Note that the increased FRET ratio indicates an increase in [lactate]i. Each data point in (ii) represents mean ± s.e.m. The initial rate of change
in [lactate]i was determined by fitting the regression lines to the initial rise of the curves. The regression line in (ii) has the form of:1FRET (%) = k (%/min) × 1t (min) +
1FRET0, where t is time, 1FRET0 is 1FRET at the time of stimulus, and the k-slope is the initial 1FRET rise: k = 3.2 ± 0.6 %/min. (B) Comparison of mean maximal
initial rates in FRET ratio changes (1FRET/1t) upon the addition of NA (200 µM), L-lactate (20 mM), 3Cl-5OH-BA (0.5 mM), CHC (6 mM), and vehicle (control) in
astrocytes. Maximal initial rates are expressed as percent change of FRET ratio per minute. Numbers by the error bars depict the number of cells analyzed.
∗∗∗P < 0.001 one-way ANOVA comparison between different types of stimuli; ##P < 0.01, ###P < 0.001 one-sample t-test. Data for every set of experiment was
acquired from at least two different animals.
the GPR81 receptor in astrocytes (Lauritzen et al., 2014;
Sharma et al., 2015). The main finding of this study is
that extracellular L-lactate in astrocytes activates AC, elevates
[cAMP]i, and accelerates aerobic glycolysis. Interestingly, by
using the selective agonists for the GPR81 receptor, such as 3Cl-
5OH-BA (Dvorak et al., 2012; Liu et al., 2012) or Compound
2 (Sakurai et al., 2014), the results revealed that even in the
absence of the GPR81 receptor expression in astrocytes from
GPR81 KO mice, elevations in [cAMP]i were still recorded,
indicating that in addition to the GPR81 receptors, these
agonists activate also a yet unidentified L-lactate receptor-like
mechanism.
L-Lactate and Adrenergic Receptor
Stimulation Increases [lactate]i in
Astrocytes
Genes associated with aerobic glycolysis are mainly expressed in
neocortical areas where neuronal cell plasticity is taking place
(Goyal et al., 2014). In these areas, astrocytes are considered
the primary site of aerobic glycolysis, and the primary source
of L-lactate release. The results of this study demonstrate that
the activation of astrocytic receptors by extracellular L-lactate
(20 mM) or the GPR81 lactate receptor agonist 3Cl-5OH-BA
(0.5 mM) (Dvorak et al., 2012) increases [lactate]i within 1 min
to a relatively high and stable level.
If the L-lactate-mediated increase in [cAMP]i is present in vivo
it may contribute to the maintenance of the L-lactate gradient
between astrocytes and neurons (Mächler et al., 2016) and also
the gradient between the extracellular L-lactate in the brain
and in the plasma (Abi-Saab et al., 2002). A positive feedback
mechanism involving L-lactate as an extracellular signal that
controls L-lactate production and subsequent L-lactate release
from astrocytes (Figure 7) may be important during neuronal
activity, when [lactate]i may rapidly decline in astrocytes due to
its facilitated exit through lactate MCTs and putative ion channels
(Sotelo-Hitschfeld et al., 2015) and/or its diffusion through the
gap junctions in astroglial syncytia (Hertz et al., 2014). Thus,
in the absence of a positive feedback mechanism, the L-lactate
concentration gradient may dissipate, reducing the availability of
L-lactate as a metabolic fuel for neurons (Barros, 2013; Mosienko
et al., 2015) and thereby limiting the support for neural network
activity.
Experiments in slices have revealed that optical activation
of astrocytes in LC triggers the release of L-lactate from
astrocytes, which then excites LC neurons and triggers the
widespread release of NA, likely in a receptor-dependent manner
involving AC and PKA activation (Tang et al., 2014). It has
been proposed that astrocytes also release L-lactate at the
axonal varicosities of the noradrenergic neurons, where it
facilitates the release of NA from the varicosities (Tang et al.,
2014). However, whether NA released from the LC neurons
affects astrocyte L-lactate production has not been studied
directly.
The real-time [lactate]i monitoring in this study revealed
that AR activation by NA can elicit a sustained increase in
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FIGURE 7 | Extracellular L-lactate controls cytosolic lactate synthesis via yet
unidentified receptors coupled to adenylate cyclase activity and cytosolic
cAMP increase in astrocytes. In the brain, L-lactate is formed in the cytoplasm
of astrocytes (IN) and is released through monocarboxylate transporters
(MCTs) 1,4 and/or lactate-permeable channels. Extracellularly (OUT), L-lactate
can be transported to neighboring cells as a fuel. However, it can also act as a
signaling molecule by binding to the L-lactate receptors of neighboring cells,
stimulating adenylate cyclase activity (AC) and an increase in cAMP synthesis.
Elevated cytosolic cAMP levels facilitate glycogen degradation by activating
glycogen phosphorylase (GP) and glycolysis with L-lactate as the end product.
In the absence of the L-lactate positive feedback mechanism (“metabolic
excitability”), the L-lactate tissue concentration gradient could be dissipated,
reducing the availability of L-lactate as a metabolic fuel, when local energy
demands, especially in the brain, are high. This model shares similarities with
the ‘autocrine lactate loop’ acting (oppositely) on [cAMP]i through GPR81
receptor in adipocytes (Ahmed et al., 2010). GS, glycogen synthase; TCA,
tricarboxylic acid cycle. Glucose denotes phosphorylated and free glucose.
[lactate]i in astrocytes, with an average time constant of ∼100
s (Supplementary Figure S2). The increase in [lactate]i is
predominantly a consequence of increased L-lactate production
in aerobic glycolysis, although changes in L-lactate fluxes across
the plasma membrane or astrocytic consumption of L-lactate
in oxidative metabolic pathway could also partly contribute
to the new L-lactate steady state levels (San Martin et al.,
2013).
The increased [lactate]i likely leads to L-lactate exiting
astrocytes, which, in vivo, may back-excite LC neurons
and further stimulate NA release (Tang et al., 2014). Such
bidirectional communication between astrocytes and neurons
may be part of a tissue-coordinated astrocyte activity, which
can be studied by monitoring widespread LC-mediated Ca2+
signaling in astrocytes in awake-behaving mice in vivo (Ding
et al., 2013; Paukert et al., 2014). Consistent with this
possibility, cultured primary cortical neurons respond to
extracellular L-lactate and the GPR81 lactate receptor agonists
with a decrease in spontaneous Ca2+-spiking activity that is
concentration-dependent, with 50% inhibitory concentration
(IC50) of ∼4 mM L-lactate (Bozzo et al., 2013), which is close
to the sensitivity of the GPR81 receptor for L-lactate (Liu et al.,
2012).
Extracellular L-Lactate-Induced Increase
in [lactate]i Involves Receptor-Like
Mediated Adenylate Cyclase Activation
and cAMP Production
In astrocytes, similar to the activation of β-ARs (Vardjan et al.,
2014; Horvat et al., 2016), extracellular L-lactate (20 mM)
and GPR81 lactate receptor agonist 3Cl-5OH-BA (0.5 mM)
elevate [cAMP]i (Figures 1A,B), as independently confirmed
by monitoring the increase in activity of cAMP effector PKA
(Figures 1D,E), but do not elevate [Ca2+]i (data not shown).
Thus, extracellular L-lactate in astrocytes likely stimulates a
plasma membrane L-lactate sensitive receptor, such as the
recently identified GPR81 receptor in brain astrocytes, which was
linked to downregulation of cAMP synthesis (Lauritzen et al.,
2014). To exclude the possibility that the addition of extracellular
L-lactate acidifies the cytoplasm, thus affecting the fluorescence
of fluorophores in a FRET nanosensor, especially the fluorescence
of YFP (Patterson et al., 2001), which declines with acidification,
producing an artifact that can be read as an increase in cAMP, we
used two different types of FRET nanosensors to monitor cAMP
activity; Epac1-camps (Nikolaev et al., 2004), and AKAR2 (Zhang
et al., 2005), which report cAMP activity in opposite directions,
as decrease and increase in YFP/CFP ratio, respectively. While in
Epac1-camps transfected cells the L-lactate application induced
a reduction in the YFP/CFP ratio, AKAR2-transfected cells
responded to L-lactate with the increase in YFP/CFP ratio. Since
the readouts from the Epac1-camps and AKAR2 YFP/CFP signals
are in opposite directions it is highly unlikely that the observed
YFP/CFP responses are due to acidification of the cytoplasm
and not a consequence of cAMP activity. Furthermore, if the
responses in cAMP and PKA activity would simply be due to a
pH-dependent artifact, then we would have recorded signals that
would be in phase with the application of L-lactate. This was not
the case. As the PKA response was significantly delayed, it is more
likely that delayed PKA activity is due to an elevation of cAMP,
followed by the cAMP-mediated activation of PKA.
Interestingly, in both mouse WT and GPR81 KO astrocytes
an increase in [cAMP]i was detected (Table 1), suggesting that
the observed effects of L-lactate and 3Cl-5OH-BA on cAMP
signaling and metabolism in astrocytes are GPR81 independent.
These results indicate the existence of a yet unidentified receptor-
like mechanism of L-lactate production, activated with L-lactate
as well as with the GPR81 selective agonists, 3Cl-5OH-BA
(Figure 1) and Compound 2 (Figure 2; Sakurai et al., 2014). The
unidentified receptor-like mechanism exhibits a relatively low
3Cl-5OH-BA affinity (we could not observe any response using
50 µM concentration) in comparison with the GPR81 lactate
receptor (EC50 = 17 µM for 3Cl-5OH-BA) (Dvorak et al., 2012).
Pretreatment of rat astrocytes with the 50 µM (subeffective)
dose of 3Cl-5OH-BA reduced the L-lactate-induced elevations
in [cAMP]i, indicating that this GPR81 receptor agonist may
share with L-lactate the binding site on a yet unidentified receptor
stimulating L-lactate production in astrocytes.
The synthesis of cAMP upon receptor activation is likely
achieved via activation of AC, as was suggested for LC neurons,
where extracellular L-lactate has been considered to activate AC
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and PKA, although the receptor triggering cAMP elevation in LC
neurons is unknown (Tang et al., 2014; Mosienko et al., 2015).
The application of DDA, an AC inhibitor, reduced the L-lactate-
mediated increase in [cAMP]i and also the 3Cl-5OH-BA-induced
increase in [lactate]i (Figure 3). An AC-dependent activity by
the 3Cl-5OH-BA-induced increase in [lactate]i appears to be
taking place also in 3T3-L1 and BT474 cells, indicating that
the Warburg effect-bearing cells regulate L-lactate synthesis via
receptors (Supplementary Table S1).
A 10-fold lower L-lactate concentration (2 mM) did not
affect [cAMP]i or [glucose]i, implying a role of L-lactate
receptor-like mechanism in vivo only at relatively elevated
extracellular L-lactate levels, as likely takes place during exercise
(Matsui et al., 2017). During abnormal conditions (e.g., hypoxia,
hyperglycemia, seizures) the local resting extracellular L-lactate
concentration of 0.1–2 mM in the narrow brain interstices
(in humans 5 mM; Abi-Saab et al., 2002) can increase ∼10-
to 20-fold to values >10 mM (Barros, 2013; Mosienko et al.,
2015). Moreover, L-lactate production in the normal brain might
occur in microdomains, which could create higher-than-average
local concentrations (Morland et al., 2015; Mosienko et al.,
2015).
In a few rat astrocytes (up to 16%, Table 1), the addition of
3Cl-5OH-BA, but not AR agonists, resulted in small sustained
decreases in [cAMP]i and PKA activity (Table 1), indicating
that in these cells, L-lactate preferentially activates receptors
coupled to the Gi-proteins to downregulate cAMP, i.e., the
coupling originally identified for GPR81 receptor (Ahmed et al.,
2010). In mouse WT and GPR81 KO astrocytes, however, the
decrease in [cAMP]i was not detected (Table 1). The observed
heterogeneity in the recorded L-lactate receptor-mediated cAMP
responses may be species specific and/or due to molecular and
functional heterogeneity of the astrocytes (Zhang and Barres,
2010), determined by the neuron-specific circuits (Chai et al.,
2017).
The time-constants of the increases in [cAMP]i and [lactate]i
were similar (58 s vs. 60 s, respectively; P = 0.90) upon 3Cl-
5OH-BA application. However, upon AR activation, the increase
in [cAMP]i was approximately fivefold faster than that for
the [lactate]i increase (20 s vs. 105 s, respectively; P < 0.001;
Supplementary Figure S2). The observed difference could be
due to the distinct molecular coupling mechanisms between the
respective receptors and the cAMP pathway generating distinct
cAMP pools inside cells (compartmentalized cAMP signaling;
Pidoux and Taskén, 2010), but altogether, the results indicate that
lactate production depends on cAMP and occurs downstream of
cAMP synthesis.
Taken together, these results show that the activation of
not only ARs but also L-lactate receptor-like mechanism can
accelerate L-lactate production in astrocytes via cAMP signaling,
suggesting the existence of a yet unidentified excitatory L-
lactate receptor in astrocytes. These findings diverge from the
previously reported results in CHO-K1 cells (Cai et al., 2008),
primary cortical neurons (Bozzo et al., 2013), homogenized
mouse adipose tissue slices (Ahmed et al., 2010), and rat
hippocampal slices (Lauritzen et al., 2014). In these tissues
L-lactate (presumably via activation of the L-lactate GPR81
receptor) was considered to inhibit cAMP and subsequent L-
lactate production.
L-Lactate Receptor-Like Mechanisms
Increase Intracellular L-Lactate More
Potently Than Adrenergic Receptors
In astrocytes the NA-mediated glycogen breakdown and
[glucose]i increase (Prebil et al., 2011) may regulate the extent
of aerobic glycolysis, a metabolic process favored in astrocytes
(Gandhi et al., 2009; Barros, 2013). Intracellular [glucose]i is
(i) a function of glucose uptake from the extracellular space,
(ii) is affected by glycogen degradation (Prebil et al., 2011),
and (iii) involves the activity of glucose-6-phosphatase, present
in astrocytes (Ghosh et al., 2005; Sharma et al., 2015), which
converts glucose-6-phosphate to free glucose.
Glycogenolysis in astroglial cells is considered to be mainly
regulated by β-ARs, although α2-ARs may also enhance it
(Subbarao and Hertz, 1990; Hertz et al., 2010). Consistent
with this possibility, the responsiveness of astrocytes to β-AR
stimulation was lower than to α-/β-AR agonist NA when
[lactate]i was measured [63% (ISO) and 90% (NA), respectively,
Table 1]. Upon the addition of 3Cl-5OH-BA, in contrast to
adrenergic stimulation, a sustained decrease in [glucose]i was
recorded, indicating that D-glucose is rapidly consumed upon
3Cl-5OH-BA-mediated L-lactate receptor-like mechanism of
activation (Figure 4). However, extracellular L-lactate triggered
only a transient decrease in D-glucose, likely due to its
interference with cytoplasmic L-lactate-sensitive enzymes (Costa
Leite et al., 2007).
To estimate the extent by which the ARs and L-lactate
receptors modulate the rate of aerobic glycolysis, we monitored
[lactate]i at rest in the presence of blocked L-lactate membrane
transport. The addition of CHC, an inhibitor of several MCTs,
resulted in a persistent increase in [lactate]i (Figure 6). If
it is assumed that L-lactate cannot exit cells under these
conditions, the putative L-lactate-permeable channels are inactive
(Sotelo-Hitschfeld et al., 2015), and L-lactate is not substantially
metabolized (Passarella et al., 2008) then the rate of change
in [lactate]i reflects the resting rate of aerobic glycolysis in
astrocytes. The addition of NA accelerated the rate of glycolysis
to only ∼30% of the resting rate, whereas in the presence of 3Cl-
5OH-BA, the glycolytic rate was increased by >600% relative to
the NA-induced response (Figure 6). Although the effectiveness
of the agonists used and their affinities for respective receptors
may not be easily compared, these results suggest that L-lactate
via receptor-like mechanism activates glycolysis more potently vs.
ARs in astrocytes.
The results of this work bring new insights that in astrocytes
L-lactate receptor-like mechanisms increase the rate of aerobic
glycolysis, which manifests itself in increased [lactate]i. This
metabolite can exit astrocytes to further accelerate L-lactate
signaling at autocrine and paracrine sites. Hence, designating this
process as “metabolic excitability” appears appropriate, as it may
provide the means for maintaining a high and stable source of
L-lactate levels in astrocytes, as measured in vivo (Mächler et al.,
2016) and likely contributes to the difference between the brain
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extracellular fluid and plasma levels of L-lactate (Abi-Saab et al.,
2002).
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